Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
Allergy Asthma Proc
; 43(4): 260-266, 2022 07 01.
Article
em En
| MEDLINE
| ID: mdl-35818144
ABSTRACT
Subcutaneous immunotherapy is recognized as a cornerstone in the management of allergic respiratory disease in patients who are properly characterized with allergy and with allergic rhinoconjunctivis and/or well-controlled asthma, and who are willing to adhere to the rigorous treatment program. A key tenet is that it affords the opportunity to effect long-term clinical remission through its disease-modifying properties. Furthermore, it has the potential to prevent the progression of allergic rhinitis to asthma, prevent new allergen sensitivities, and improve a patient's quality of life.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transtornos Respiratórios
/
Asma
/
Rinite Alérgica
Limite:
Humans
Idioma:
En
Revista:
Allergy Asthma Proc
Assunto da revista:
ALERGIA E IMUNOLOGIA
Ano de publicação:
2022
Tipo de documento:
Article